— Know what they know.
Not Investment Advice
Also trades as: IGAP (NASDAQ) · $vol 0M

GCTK NASDAQ

GlucoTrack, Inc.
1W: -33.5% 1M: -65.7% 3M: -74.6% YTD: -97.9% 1Y: -98.7% 3Y: -100.0% 5Y: -100.0%
$1.21
-0.20 (-14.18%)
 
Weekly Expected Move ±25.9%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 26 · $965753 mcap · 641159 float · 134.41% daily turnover · Short 41% of daily vol

Cash Flow Trends

Operating Cash Flow
-$15M -22.0% ▼
Capital Expenditures
$96K +7.7% ▲
5Y CAGR: +12.6%
Free Cash Flow
-$15M -21.8% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$2M +56.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$4M-$4M-$7M-$23M$0
Depreciation & Amort.$42K$23K$13K$36K$42K
Stock-Based Comp.$223K$439K$281K$173K$211K
Change in Working Capital-$53K$184K$190K$67K$0
Other Non-Cash Items$44K$60K$55K$10M-$15M
Operating Cash Flow-$4M-$4M-$7M-$12M-$15M
— Investing Activities —
Capital Expenditures-$5K-$1K$0-$104K-$96K
Acquisitions (Net)$0$2K$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$4K$2$0$0$0
Investing Cash Flow-$1K$1K$0-$104K-$96K
— Financing Activities —
Net Debt Issuance$0$0$0$4M$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$85K$17M
Financing Cash Flow$0$0$9M$14M$17M
Net Change in Cash-$4M-$4M$2M$1M$2M
Cash End of Period$6M$2M$5M$6M$7M
Free Cash Flow-$4M-$4M-$7M-$13M-$15M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms